The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease.

Carvey, P M; McRae, A; Lint, T F; Ptak, L R; Lo, E S; Goetz, C G; Klawans, H L

Carvey, P M; McRae, A; Lint, T F; Ptak, L R; Lo, E S; Goetz, C G; Klawans, H L.

Affiliation

Carvey PM; Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612.

Neurology ; 41(5 Suppl 2): 53-8; discussion 59-60, 1991 May.

Article in En | MEDLINE | ID: mdl-2041594

Subject(s)

Antibodies/analysis; Corpus Striatum/metabolism; Dopamine/metabolism; Nerve Tissue Proteins/metabolism; Neurons/immunology; Parkinson Disease/diagnosis; Adrenal Medulla/transplantation; Biomarkers; Brain/physiopathology; Cerebrospinal Fluid/physiology; Humans; Mesencephalon/metabolism; Nerve Growth Factors/metabolism; Neurons/metabolism; Parkinson Disease/immunology; Parkinson Disease/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Dopamine / Corpus Striatum / Antibodies / Nerve Tissue Proteins / Neurons Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Neurology Year: 1991 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links